Evidence map›Paper›PMID 21288997›Full record

ArticleClinical and vaccine immunology : CVI2011

Serum IgG response to Cryptosporidium immunodominant antigen gp15 and polymorphic antigen gp40 in children with cryptosporidiosis in South India.

Sitara Swarna Rao Ajjampur, Rajiv Sarkar, Geneve Allison, Kalyan Banda, Anne Kane, Jayaprakash Muliyil, Elena Naumova, Honorine Ward, Gagandeep Kang

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. An update onJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Review
  5. Serum IgG Responses to gp15 and gp40 Protein-Derived Synthetic Peptides FromFrontiers in cellular and infection microbiology · 2021
    Article
  6. Review
  7. Article
  8. Case-Control Study of Cryptosporidium Transmission in Bangladeshi Households.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  9. Asparagine-Linked Glycans ofMolecular & cellular proteomics : MCP · 2017
    Article
  10. Article
  11. Article
  12. Systemic and Mucosal Immune Responses toCurrent tropical medicine reports · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Cryptosporidiosis among children in an endemic semiurban community in southern India: does a protected drinking water source decrease infection?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sitara Swarna Rao AjjampurDepartment of Gastrointestinal Sciences, Christian Medical College, Vellore, TN 632004, India.
Rajiv Sarkar
Geneve Allison
Kalyan Banda
Anne Kane
Jayaprakash Muliyil
Elena Naumova
Honorine Ward
Gagandeep Kang
Christian Medical College & Hospital · INTufts University · USTufts Medical Center · US

Funding

Immune Response to Cryptosporidiosis in a Birth Cohorot of Children of South IndiR01AI072222 · NIAID · TUFTS MEDICAL CENTER · PI WARD, HONORINE D · 2008 to 2012
$3.1M
Multi-disciplinary research training in enteric infectionsD43TW007392 · FIC · CHRISTIAN MEDICAL COLLEGE · PI KANG, GAGANDEEP · 2005 to 2020
$2.9M
HIV PATHOGENESIS TRAINING PROGRAMT32AI007389 · NIAID · TUFTS MEDICAL CENTER · PI WARD, HONORINE D · 1990 to 2011
$2.3M
Molecular Basis of Crytosporidium-Host cell InteractionR01AI052786 · NIAID · TUFTS MEDICAL CENTER · PI WARD, HONORINE D · 2003 to 2007
$1.8M
FIC NIH HHS D43 TW007392FIC NIH HHS R03 TW2711NIAID NIH HHS R01 AI052786NIAID NIH HHS R01 AI072222NIAID NIH HHS R01 AI52786NIAID NIH HHS T32 AI007389NIAID NIH HHS T32 AI07389
6 · The paper itself

Abstract

The surface-associated glycopeptides gp40, one of the most polymorphic Cryptosporidium antigens, and gp15, one of the most immunodominant Cryptosporidium antigens, are putative vaccine candidates because they mediate infection in vitro and induce immune responses in vivo. We evaluated antibody responses to these antigens before and after the first episode of symptomatic cryptosporidiosis in 51 children from a birth cohort study in an area in South India where Cryptosporidium is endemic and a major cause of parasitic diarrhea. IgG levels to gp15 and to homotypic and heterotypic gp40 antigens were measured in pre- and postdiarrheal sera by enzyme-linked immunosorbent assay (ELISA). There was a significant IgG response to gp15 (P < 0.001) following the first episode of cryptosporidial diarrhea. Using a general additive model, we determined the estimated time of the peak IgG response to gp15 to be 9.3 weeks (confidence interval, 5.2 to 13.4) following the diarrheal episode. In a subset of 30 children infected with Cryptosporidium hominis subtype Ia, there was a significant difference in IgG responses to homotypic C. hominis Ia and to heterotypic Cryptosporidium parvum II gp40 antigens (P = 0.035). However, there was also a significant correlation (P = 0.001) in the responses to both antigens in individual children, suggesting that while responses are in part subtype specific, there is significant cross-reactivity to both antigens. This is the first report of the characterization of immune responses to cryptosporidiosis in Indian children and the first study to investigate human immune responses to the polymorphic gp40 antigen. However, further studies are needed to determine whether immune responses to these antigens are protective against subsequent infections.

Indexed as

Antibodies, ProtozoanAntigens, ProtozoanChild, PreschoolCross ReactionsCryptosporidiosisCryptosporidium parvumEnzyme-Linked Immunosorbent AssayHumansImmunodominant EpitopesImmunoglobulin GIndiaInfantInfant, NewbornProtozoan ProteinsAntibodies, ProtozoanAntigens, ProtozoanCpgp40-15 protein, Cryptosporidium parvumImmunodominant EpitopesImmunoglobulin GProtozoan Proteins

Identifiers

PMID21288997
PMCPMC3122581
OpenAlexW2117323415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.